Drug class in one race
Amylin receptor drugs for Type 2 Diabetes
4 tracked Amylin receptor drugs in the Type 2 Diabetes race. The class explanation lives on the Amylin receptor page; the full indication pipeline across every mechanism is on the Type 2 Diabetes page.
4 Phase 3
Head-to-head evidence: amycretin vs MET-097i · cagrilintide vs MET-097i · cagrilintide/semaglutide vs MET-097i · amycretin vs cagrilintide · amycretin vs cagrilintide/semaglutide · cagrilintide vs cagrilintide/semaglutide